Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants
Clinical trial NCT07570069 · COMPLETED
Trial details
- NCT number
- NCT07570069
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-07
- Primary completion
- 2026-07-16
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.